# Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients

> **NCT00997022** · PHASE1 · COMPLETED · sponsor: **Columbia University** · enrollment: 14 (actual)

## Conditions studied

- Hepatocellular Cancer

## Interventions

- **DRUG:** Sorafenib

## Key facts

- **NCT ID:** NCT00997022
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2015-08-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997022, "Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00997022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*